Dapaglif 10 Mg 14 Tablets

Dapaglif 10 Mg 14 Tablets

Description:

Dapaglif 10 mg 14 tablets (Dapaglif 10 mg 14 f.c. tabs.) is an oral prescription antidiabetic medicine containing dapagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor. It is used as part of a comprehensive diabetes care plan to help control blood glucose levels in adults with type 2 diabetes mellitus. By blocking SGLT2 in the kidneys, dapagliflozin reduces glucose reabsorption and increases glucose excretion in the urine, helping to lower fasting and postprandial blood sugar and improve overall glycemic control. This product is intended for medical use under the supervision of a healthcare professional.

Indications:

• Management of type 2 diabetes mellitus in adults, as monotherapy when diet and exercise alone do not provide adequate glycemic control and when metformin is considered inappropriate due to intolerance or contraindications.
• Adjunctive therapy to other antidiabetic agents (such as metformin, sulfonylureas, insulin) in adults with type 2 diabetes mellitus to improve glycemic control.
• Helps reduce elevated fasting and postprandial blood glucose levels and HbA1c in patients with type 2 diabetes.
• May contribute to modest weight reduction and blood pressure lowering as part of overall metabolic management in type 2 diabetes (as observed in clinical practice and studies).
• Not indicated for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis.

Active Ingredients / Key Components:

• Dapagliflozin – 10 mg per film-coated tablet.
• Other tablet excipients (film-coating and core ingredients such as fillers, binders, disintegrants, colorants, and preservatives) are present but specific names and concentrations , please check the product leaflet or the manufacturer’s official website.

Dosage & Administration / How to Use:

• Usual adult dose: 10 mg dapagliflozin (one tablet) once daily, as directed by your physician.
• Tablets should be swallowed whole with a sufficient amount of water; do not crush, chew, or split unless advised by your doctor.
• Can be taken with or without food, preferably at the same time each day to maintain consistent blood levels.
• Dose adjustment may be required when used in combination with insulin or insulin secretagogues (e.g., sulfonylureas) to reduce the risk of hypoglycemia; follow your doctor’s instructions.
• Renal function should be assessed before initiation and periodically during treatment; dosing or continuation may be modified based on kidney function according to your physician’s judgment.
• If you miss a dose, take it as soon as you remember on the same day. If it is almost time for the next dose, skip the missed dose and resume your regular schedule. Do not double the dose to make up for a missed tablet.
• Use this medicine exactly as prescribed. Do not change the dose, stop, or restart treatment without consulting your healthcare provider.
• Continue following your prescribed diet, exercise plan, and regular blood glucose monitoring while using Dapaglif 10 mg.

Clinical Benefits:

• Helps lower elevated blood glucose levels in adults with type 2 diabetes by promoting urinary glucose excretion through SGLT2 inhibition in the kidneys.
• Improves long-term glycemic control, as reflected by reductions in HbA1c when used alone or in combination with other antidiabetic medications.
• Provides an insulin-independent mechanism of action, making it useful as an add-on therapy to various antidiabetic regimens.
• May support modest weight loss and reduction in systolic blood pressure in many patients as part of overall metabolic management (individual results may vary).

Warnings & Contraindications:

• Contraindicated in patients with known hypersensitivity to dapagliflozin or any of the tablet components.
• Not recommended for use in patients with type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis due to increased risk of ketoacidosis.
• Use with caution in patients with impaired renal function; efficacy may be reduced and risk of adverse effects (such as volume depletion) may increase. Your doctor will determine suitability based on kidney function tests.
• May increase the risk of genital mycotic infections and urinary tract infections; maintain good personal hygiene and seek medical advice if symptoms occur.
• Can cause volume depletion (dehydration), dizziness, or low blood pressure, especially in elderly patients, those on diuretics, or with low blood pressure; ensure adequate fluid intake and report symptoms such as dizziness or fainting.
• Monitor for signs and symptoms of ketoacidosis (nausea, vomiting, abdominal pain, excessive thirst, difficulty breathing, confusion, unusual fatigue); seek urgent medical attention if these occur even if blood glucose is not markedly elevated.
• Consult your doctor before use if pregnant, planning pregnancy, or breastfeeding; safety data in pregnancy and lactation are limited, and alternative treatments may be preferred.
• Consult your doctor before use if you have liver disease, recurrent urinary tract or genital infections, low blood pressure, cardiovascular disease, or are taking diuretics, antihypertensives, or other antidiabetic medications.
• Not intended to diagnose, treat, cure, or prevent any disease without proper medical supervision; it is a prescription medicine that must be used under a doctor’s guidance.
• Keep out of reach of children.

Side Effects:

• Common side effects may include increased urination, genital fungal infections (such as vulvovaginal candidiasis or balanitis), urinary tract infections, thirst, and mild dehydration.
• Other possible side effects: dizziness, low blood pressure (especially in volume-depleted patients), increased cholesterol levels, and rash or hypersensitivity reactions in susceptible individuals.
• Serious but less common side effects may include diabetic ketoacidosis (including euglycemic ketoacidosis), severe urinary tract infections (such as pyelonephritis), and significant volume depletion. Seek immediate medical attention if you experience severe abdominal pain, vomiting, difficulty breathing, confusion, high fever, or signs of severe infection.
• Hypoglycemia is more likely when dapagliflozin is used in combination with insulin or insulin secretagogues; symptoms include sweating, tremor, hunger, palpitations, headache, and confusion. Check blood glucose and follow your doctor’s instructions if symptoms occur.
• If you notice any unusual or persistent symptoms, discontinue use and consult your healthcare provider promptly.

Storage Instructions:

Store in a cool, dry place away from direct sunlight. Keep container tightly closed. Keep out of reach of children.

Specifications:

• Serving size: 1 tablet (containing 10 mg dapagliflozin).
• Count: 14 film-coated tablets per pack.
• Form: Oral film-coated tablet.
• Intended use: Prescription antidiabetic medicine for adults with type 2 diabetes mellitus.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.